← SynDRA
MB-05032
SynDRA canonical compound SYN0014176 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | FBP1 |
|---|
| Mechanism of action | Fructose biphosphate inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Fructose biphosphate inhibitor
- Modulator
Cross-references
Synonyms
- MB05032
- Managlinat dialanetil
- CS-917
- GP-3034
- MB-06322
- MB-06633
- MB-6322
- R-132917
- Type 2 diabetes therapeutic, Gensia/Sankyo
- Type 2 diabetes therapeutic, SICOR/Sankyo
- Diabetes therapeutics, Metabasis/Sanyko/Daiichi Sankyo
- Purine nucleotide analogs, Gensia/Sankyo/Daiichi Sankyo
- Purine nucleotide analogs, Metabasis/Sanyko/Daiichi Sankyo
- Purine nucleotide analogs, SICOR/Sankyo/Daiichi Sankyo
- RefChem:925378
- C11H15N2O4PS
- 2-Amino-5-isobutyl-4-(5-PHOSPHONO-2-furanyl)thiazole
- UNII-9379MH4CAL
- orb1707009
- SCHEMBL2742711
- XJMYIJPPDSZOPN-UHFFFAOYSA-N
- GLXC-15875
- BDBM50293594
- EX-A14572
- AKOS015957645
- CS-1552
- DA-55262
- HY-16307
- VU0549312-1
- EN300-238163
- F84965
- T16020
- F496428
- BRD-K35601925-001-01-9
- BRD-K35601925-001-02-7
- F9995-0175
- [5-(2-amino-5-isobutyl-thiazol-4-yl)-2-furyl]phosphonic acid
- 5-(2-amino-5-isobutylthiazol-4-yl)furan-2-ylphosphonic acid
Look up MB-05032 in the interactive SynDRA portal →